Polyethylene glycol 3350 and Thrombocytopenia - a phase IV clinical study of FDA data

Summary:

Thrombocytopenia is found among people who take Polyethylene glycol 3350, especially for people who are male, 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Polyethylene glycol 3350 and have Thrombocytopenia. It is created by eHealthMe based on reports of 1,512 people who have side effects when taking Polyethylene glycol 3350 from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 26, 2022

1,512 people reported to have side effects when taking Polyethylene glycol 3350.
Among them, 29 people (1.92%) have Thrombocytopenia.


What is Polyethylene glycol 3350?

Polyethylene glycol 3350 has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 1,634 Polyethylene glycol 3350 users for its effectiveness, alternative drugs and more.

What is Thrombocytopenia?

Thrombocytopenia (decrease of platelets in blood) is found to be associated with 3,883 drugs and 4,400 conditions by eHealthMe.

Number of Polyethylene glycol 3350 and Thrombocytopenia reports submitted per year:

Could Polyethylene glycol 3350 cause Thrombocytopenia?

Time on Polyethylene glycol 3350 when people have Thrombocytopenia *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Thrombocytopenia when taking Polyethylene glycol 3350 *:

  • female: 32.14 %
  • male: 67.86 %

Age of people who have Thrombocytopenia when taking Polyethylene glycol 3350 *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 7.69 %
  • 20-29: 11.54 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 46.15 %
  • 60+: 34.62 %

Common drugs people take besides Polyethylene glycol 3350 *:

  1. Furosemide: 16 people, 55.17%
  2. Acyclovir: 16 people, 55.17%
  3. Hydrochlorothiazide: 13 people, 44.83%
  4. Propofol: 13 people, 44.83%
  5. Metronidazole: 11 people, 37.93%
  6. Amlodipine Besylate: 11 people, 37.93%
  7. Lansoprazole: 11 people, 37.93%
  8. Ciprofloxacin: 10 people, 34.48%
  9. Metformin: 10 people, 34.48%
  10. Meropenem: 10 people, 34.48%

Common side effects people have besides Thrombocytopenia *:

  1. Leukocytosis (increased white blood cells): 11 people, 37.93%
  2. Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 10 people, 34.48%
  3. Eosinophilia (eosinophil count in the peripheral blood exceeds): 10 people, 34.48%
  4. White Blood Cell Count Decreased: 7 people, 24.14%
  5. Fever: 6 people, 20.69%
  6. Breathing Difficulty: 5 people, 17.24%
  7. Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 13.79%
  8. Hypotension (abnormally low blood pressure): 4 people, 13.79%
  9. Haemoglobin Decreased: 4 people, 13.79%
  10. Weight Decreased: 3 people, 10.34%

Common conditions people have *:

  1. Sedation: 10 people, 34.48%
  2. Type 2 Diabetes: 10 people, 34.48%
  3. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 20.69%
  4. Nausea (feeling of having an urge to vomit): 5 people, 17.24%
  5. Pain: 5 people, 17.24%
  6. Nausea And Vomiting: 4 people, 13.79%
  7. Diabetes: 4 people, 13.79%
  8. Fever: 2 people, 6.90%
  9. Diarrhea: 2 people, 6.90%
  10. Stress And Anxiety: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Polyethylene glycol 3350 and have Thrombocytopenia?

Check whether Thrombocytopenia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Thrombocytopenia and when was it recovered:

Expand to all the drugs that have ingredients of polyethylene glycol 3350:

Alternative drugs to, pros and cons of Polyethylene glycol 3350:

Common Polyethylene glycol 3350 side effects:

Browse all side effects of Polyethylene glycol 3350:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Thrombocytopenia treatments and more:

COVID vaccines that are related to Thrombocytopenia:

Common drugs associated with Thrombocytopenia:

All the drugs that are associated with Thrombocytopenia:

Common conditions associated with Thrombocytopenia:

All the conditions that are associated with Thrombocytopenia:

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Polyethylene glycol 3350) and Polyethylene glycol 3350 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: